Dermatology News and Research

Latest Dermatology News and Research

Mayo Clinic launches healthy living program aimed to help people achieve and sustain wellness

In a crowded health and wellness marketplace, knowing what's fact versus myth and effective versus ineffective can be a challenge. It also may be an obstacle for some people to find a sound and practical lifestyle program that they can maintain over time. To provide a comprehensive wellness program based on research, not the trend of the day, Mayo Clinic will launch the Mayo Clinic Healthy Living Program in summer of 2014 to help people adopt healthy behavioral changes in diet, exercise and stress management and improve their overall quality of life.

1 May 2014

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Actavis plc today reported net revenue increased 40 percent to $2.66 billion for the first quarter ended March 31, 2014, compared to $1.90 billion in the first quarter 2013.

30 Apr 2014

Endo enters into definitive agreement to acquire Grupo Farmaceutico Somar

Endo International plc today announced it has entered into a definitive agreement under which Endo will acquire Grupo Farmaceutico Somar, a leading privately-owned specialty pharmaceuticals company based in Mexico City, Mexico, for cash consideration. Endo expects the transaction to be immediately accretive to adjusted earnings per share.

29 Apr 2014

Actavis' subsidiary files lawsuit against FDA over Celebrex decision

Actavis plc today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.

29 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

Skin Cancer Awareness Month and Melanoma Monday: Mount Sinai experts to share vital skin cancer tips

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. In recognition of May's Skin Cancer Awareness Month and Melanoma Monday on May 5th, Mount Sinai Health System experts are arming the public with vital tips on prevention and offering FREE skin cancer screenings.

26 Apr 2014

American Academy of Dermatology awarded 22 organizations with Shade Structure Grants

In an effort to provide children and adolescents more opportunities to play outside while being protected from the sun's dangerous rays, the American Academy of Dermatology (Academy) has awarded 22 organizations with Shade Structure Grants.

26 Apr 2014

Nuvo Research collaborates with Ferndale to develop 2 topical dermatology products

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. and a leading Contract Research Organization with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer technology.

23 Apr 2014

Uncontrollable sweating of hyperhidrosis can have serious impact on person

Sweating is a natural function of the body to cool it down during physical exertion or from a warm environment or to even help cope with emotional situations.

23 Apr 2014

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079), evaluating the efficacy and safety of tofacitinib, an oral Janus kinase (JAK) inhibitor, the first in a new class of medicines being investigated for the treatment of moderate-to-severe plaque psoriasis.

23 Apr 2014

Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.

22 Apr 2014

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

Rural residents who commonly seek treatment for advanced stages of colorectal cancer have been thought to lack access to cancer screening and adjuvant therapy. ... Several theories have been postulated to explain these findings, some of which include low socioeconomic status, lower educational attainment, lack of insurance coverage, underinsurance, and travel distance to health care facilities.

21 Apr 2014

FTC requests additional information relating to Actavis’ pending acquisition of Forest Laboratories

Actavis plc and Forest Laboratories, Inc. today announced that they have each received a request for additional information from the Federal Trade Commission ("FTC") in connection with Actavis' pending acquisition of Forest.

18 Apr 2014

Actavis to purchase four currently marketed products from Akorn

Actavis plc, a leading global specialty pharmaceutical company, today announced that it has entered into agreements with Akorn, Inc. and Hi-Tech Pharmacal Co. Inc. to purchase four currently marketed products and one product under development

18 Apr 2014

Free medication samples in dermatology offices appear to change prescribing practices for acne

The availability of free medication samples in dermatology offices appears to change prescribing practices for acne, a common condition for which free samples are often available.

17 Apr 2014

New initiative aims to develop Global Psoriasis Atlas

While studies over the recent years have contributed to an improved understanding of psoriasis, there are still significant gaps in knowledge related to the epidemiology of this serious, chronic disease and trends in incidence over time. The World Health Organization, reported in 2013 that the worldwide prevalence of psoriasis is around 2%, but that studies in developed countries have declared prevalence rates of more than twice the global estimate at an average of 4.6% .

15 Apr 2014

Penn Medicine to host symposium on regenerative medicine

The University of Pennsylvania's Institute for Regenerative Medicine will host a symposium on Friday, April 11, 2014 to detail the progress researchers are making toward reprogramming human cells to treat a variety of diseases.

9 Apr 2014

Forest Laboratories, Almirall receive feedback from FDA regarding fixed dose combination of aclidinium/formoterol

Forest Laboratories, Inc. and Almirall, S.A. today announced that they have recently received feedback from the U.S. Food and Drug Administration (FDA) regarding the fixed dose combination of aclidinium and formoterol.

9 Apr 2014

Chromogenex launches non-surgical fat reduction and body shaping system

Chromogenex, a world leader in laser innovation, announced today the launch of i-LipoXcell, the company's non-surgical fat reduction and body shaping system. Representing third generation technology, i-LipoXcell incorporates both visible red and infrared lasers for bio-stimulation of metabolic pathways, effectively shrinking fat cells through the release of fatty acids and glycerol.

7 Apr 2014

Meda reaches agreement with Valeant to terminate joint ventures

Meda has reached an agreement with Valeant to terminate the companies' joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda affiliates have been established.

7 Apr 2014

Dermatology News and Research

Latest Dermatology News and Research

Mayo Clinic launches healthy living program aimed to help people achieve and sustain wellness

Actavis’ net revenue increases 40% to $2.66B in Q1 2014

Endo enters into definitive agreement to acquire Grupo Farmaceutico Somar

Actavis' subsidiary files lawsuit against FDA over Celebrex decision

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Skin Cancer Awareness Month and Melanoma Monday: Mount Sinai experts to share vital skin cancer tips

American Academy of Dermatology awarded 22 organizations with Shade Structure Grants

Nuvo Research collaborates with Ferndale to develop 2 topical dermatology products

Uncontrollable sweating of hyperhidrosis can have serious impact on person

Pfizer reports positive results from two tofacitinib Phase 3 trials for moderate-to-severe plaque psoriasis

Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

FTC requests additional information relating to Actavis’ pending acquisition of Forest Laboratories

Actavis to purchase four currently marketed products from Akorn

Free medication samples in dermatology offices appear to change prescribing practices for acne

New initiative aims to develop Global Psoriasis Atlas

Penn Medicine to host symposium on regenerative medicine

Forest Laboratories, Almirall receive feedback from FDA regarding fixed dose combination of aclidinium/formoterol

Chromogenex launches non-surgical fat reduction and body shaping system

Meda reaches agreement with Valeant to terminate joint ventures

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in